Monocarboxylate transporter 4 (MCT4) is a member of the monocarboxylate transporter family, which is responsible for the transport of monocarboxylates, such as lactate and pyruvate, across cell membranes. These transporters play a crucial role in metabolic processes, particularly in cells that undergo glycolysis at a high rate and produce an abundance of lactate as a byproduct. MCT4 is distinctively expressed in cells and tissues that have high glycolytic rates and is pivotal in facilitating the efflux of lactate out of these cells. In doing so, MCT4 ensures that the intracellular environment remains conducive to continuous glycolytic activity by preventing the accumulation of excess lactate which could impede the glycolytic pathway.
MCT4 inhibitors are chemical compounds designed to specifically impede the function of MCT4. By inhibiting MCT4, these molecules can modulate the intracellular and extracellular concentrations of lactate and other monocarboxylates, affecting the metabolic dynamics of the cell. The interaction between MCT4 inhibitors and the transporter can be achieved through various mechanisms, including direct binding to the transporter, altering its conformation, or competing with its natural substrates.
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
AR-C155858 | 496791-37-8 | sc-480179 sc-480179A sc-480179B sc-480179C | 1 mg 5 mg 10 mg 50 mg | $362.00 $764.00 $1280.00 $3743.00 | ||
AR-C155858 is a selective MCT1 and MCT2 inhibitor. While its primary target is not MCT4, it may indirectly affect MCT4 expression by altering cellular lactate dynamics and metabolic adaptations. | ||||||
Sodium dichloroacetate | 2156-56-1 | sc-203275 sc-203275A | 10 g 50 g | $54.00 $205.00 | 6 | |
Dichloroacetate, which shifts metabolism from glycolysis to oxidative phosphorylation, might reduce MCT4 expression due to decreased lactate production. | ||||||
1,1-Dimethylbiguanide, Hydrochloride | 1115-70-4 | sc-202000F sc-202000A sc-202000B sc-202000C sc-202000D sc-202000E sc-202000 | 10 mg 5 g 10 g 50 g 100 g 250 g 1 g | $20.00 $42.00 $62.00 $153.00 $255.00 $500.00 $30.00 | 37 | |
As an AMPK activator, metformin might down-regulate MCT4 by altering cellular energy status and metabolic pathways. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $65.00 $210.00 | 26 | |
By inhibiting glycolysis, 2-deoxyglucose can potentially reduce lactate production and subsequent MCT4 expression required for its efflux. | ||||||
Phenformin Hydrochloride | 834-28-6 | sc-219590 | 10 g | $117.00 | 4 | |
As a biguanide, phenformin can affect cellular metabolism and might reduce MCT4 expression by decreasing the cellular reliance on glycolysis. | ||||||
Lonidamine | 50264-69-2 | sc-203115 sc-203115A | 5 mg 25 mg | $103.00 $357.00 | 7 | |
Lonidamine inhibits glycolysis and can potentially decrease MCT4 expression by reducing cellular lactate levels. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $108.00 $245.00 $918.00 $49.00 | 33 | |
Quercetin, a flavonoid, might suppress MCT4 expression through its effects on cellular metabolism and signaling pathways related to cancer. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $60.00 $270.00 $350.00 | 48 | |
As an AMPK activator, AICAR might alter cellular energy balance and reduce MCT4 expression by decreasing glycolytic activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
By inhibiting mTOR signaling, rapamycin might down-regulate MCT4 as part of a broader effect on cellular metabolism and growth. | ||||||
Bufotalin | 471-95-4 | sc-202509 | 5 mg | $200.00 | ||
Oxamate inhibits lactate dehydrogenase, reducing lactate production and potentially decreasing the need for MCT4-mediated efflux. |